| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $743.9M | +16.6% |
| R&D Expense | $146.2M | +30.1% |
| SG&A Expense | $110.7M | -6.3% |
| Operating Income | -$66.3M | +57.0% |
| Pre-tax Income | -$70.3M | +60.0% |
| Income Tax | $2.8M | +825.3% |
| Net Income | -$73.1M | +58.3% |
| EPS (Basic) | -$0.63 | +59.4% |
| EPS (Diluted) | -$0.63 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.4M | +22.1% |
| Short-term Investments | $26.2M | -41.5% |
| Accounts Receivable | $62.3M | +8.5% |
| Current Assets | $273.1M | -0.9% |
| Total Assets | $841.8M | -7.5% |
| Current Liabilities | $229.9M | +20.0% |
| Total Liabilities | $741.9M | +1.9% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $48.8M | +40.7% |
| Capital Expenditures | $3.0M | -27.7% |
| Investing Cash Flow | $6.0M | +103.8% |
| Financing Cash Flow | -$37.8M | -135.8% |
| Free Cash Flow | $45.8M | +49.9% |
| +59.4% |
| Stockholders' Equity |
| $99.9M |
| -45.2% |